申请人:BASF Aktiengesellschaft
公开号:US04399137A1
公开(公告)日:1983-08-16
6-Imidazol-1-yl-3-hydrazino-pyridazines, in which the imidazole ring is unsubstituted or is substituted by halogen or alkyl, their physiologically tolerated addition salts with acids, processes for their preparation and their use as drugs in the treatment of hypertonia.
6-咪唑-1-基-3-肼基-吡啶嗪,其中咪唑环未被取代或被卤素或烷基取代,其与酸的生理耐受性加成盐,其制备过程以及它们作为治疗高血压的药物的用途。